NOTCH3 and hepatocellular carcinoma: A similar study with sorafenib demonstrated improved efficacy of this multi-kinase inhibitor in HCC in vitro and in vivo following Notch3 inhibition, which promoted GSK3β phosphorylation and p21 downregulation [57].